Drug Design and Development

Bioavailability and Bioequivalence

Bioavailability can be defined as the amount of drug available at the target site after systemic circulation and Bioequivalence is the similarity of two drugs which release the active ingredients at the same rate, amount, &quality. In such a process, the new drugs are tested for their stability studies. The new formulations have to undergo the analytical process to get approved by the FDA as an effective and safe dosage form. It has to compare new drug with the standard product as a reference.